Chlorothiazide Sodium
CHLOROTHIAZIDE SODIUM FOR INJECTION, USP
Approved
Approval ID
850960a3-9fe2-4999-81eb-b0ae9ba011bc
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 5, 2020
Manufacturers
FDA
American Regent, Inc.
DUNS: 002033710
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Chlorothiazide Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0517-1820
Application NumberANDA202561
Product Classification
M
Marketing Category
C73584
G
Generic Name
Chlorothiazide Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 5, 2020
FDA Product Classification
INGREDIENTS (3)
MANNITOLInactive
Quantity: 250 mg in 18 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
CHLOROTHIAZIDE SODIUMActive
Quantity: 500 mg in 18 mL
Code: SN86FG7N2K
Classification: ACTIM